ArticleAging2024

Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing to chemotherapy and targeted therapy in liver hepatocellular carcinoma.

Yitong Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.